News | Information Technology | January 16, 2017

Top 18 Technologies Fueling Growth Opportunities in Global Healthcare

Stakeholders that are not invested in any of these by 2025 will fall behind the curve, finds Frost & Sullivan’s Transformational Health team

Frost & Sullivan, 18 technologies, growth opportunities, global healthcare, information technology, 2025

January 16, 2017 — Frost & Sullivan has released a new report, “Vision 2025 – Future of Healthcare,” part of the company’s Advanced Medical Technologies, that identifies 18 technologies that will impact healthcare paradigms by 2025.

Technology-driven transformation in global healthcare demands that stakeholders identify influential technologies and re-strategize to ride the strongest growth currents. As healthcare moves to the anytime, anyplace, continuous and personalized care model, technological advances are unlocking values and previously inaccessible segments.

“Although these technologies are making waves within research, two aspects must be weighed to assess potential market impact,” noted Frost & Sullivan Transformational Health Research Analyst Siddharth Shah. “The first is the commercialization and maturity timelines for these technologies. The second is aligning the technologies with Healthcare 2025 trends and themes in order to successfully leverage growth opportunities.”

Some technologies set to create billion-dollar opportunities, according to the report, include: wearables, enhanced prosthetics, nanorobotics, electroceuticals, advanced materials, population health analytics, quantum computing, wellness gamification, regenerative medicine and precision medicine.

To be profitable, companies must identify the technologies that will impact their business and invest accordingly, according to Frost & Sullivan. For instance:

  • Artificial intelligence (AI) is set to speed up the analysis of large volumes of data to efficiency levels that exceed human capability;
  • Brain-computer interfaces can connect a “wired” brain directly with an external device for “neural bypass,” which will help paralyzed patients move or blind patients see;
  • Digital avatars offer holographic projections of doctors to answer health queries, similar to voice assistants like Cortana and Siri; and
  • Medical tricorders can record health vitals and parameters to diagnose a range of health conditions without a physician.

Frost & Sullivan’s analysis offers timeframes for commercialization and indicates when significant on-the-ground healthcare impact will be seen for each technology. Some of the frontrunners in the race for enabling healthcare technologies include IBM Watson Health with its AI for healthcare, Organovo for 3-D bioprinting, DeepStream VR for its virtual reality applications, and QualComm with its $10 million tricorderX inducement prize contest to develop medical tricorders.

For more information: www.frost.com

Related Content

NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO). CRF sponsors TCT.

The Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO).

Feature | Cath Lab| September 12, 2017
September 12, 2017 – The Cardiovascular Research Foundation (CRF) a
Systolic Blood Pressure at Time of STEMI PCI May Predict In-Hospital Mortality
News | Cath Lab| September 11, 2017
September 11, 2017 — Researchers have led a retrospective single-center...
PURE study may cause revision of fat intake guidelines for cardiology.
Feature | ESC| September 07, 2017
September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of
Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing| September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure| September 06, 2017
September 6, 2017 — Physicians identified a majority of patients with advanced...
Overlay Init